← Back to Search

PET-MRI for Blood Cancers

N/A
Waitlist Available
Led By Michael Gee, MD, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to lie comfortably on a bed inside the scanner for 60 minutes as assessed by physical examination and medical history
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial is testing PET/MRI to see if it can accurately detect and characterize cancerous tumors, compared to the reference standard PET/CT.

Eligible Conditions
  • Blood Cancers

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Comparison of Imaging Quality between PET-MRI and PET-CT
Secondary outcome measures
Assessment of Unexpected Indeterminate Lesions
Comparison of PET-MRI SUV Values and PET-CT FDG Reference

Trial Design

1Treatment groups
Experimental Treatment
Group I: ImagingExperimental Treatment2 Interventions
PET-MRI PET-CT
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PET-MRI
2018
N/A
~100
PET-CT
2014
N/A
~570

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,929 Previous Clinical Trials
13,198,285 Total Patients Enrolled
1 Trials studying Blood Cancers
90 Patients Enrolled for Blood Cancers
Michael Gee, MD, PhDPrincipal InvestigatorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who fulfills the requirements to be considered a participant in this clinical experiment?

"To qualify for this medical trial, applicants must have a hematologic neoplasm and fit within the age range of 5 to 18. A total of 20 people are slated to be recruited."

Answered by AI

Is there an ongoing recruitment period for this research project?

"Based on the information provided by clinicaltrials.gov, this trial is still enrolment participants and was last modified on August 30th 2021 - since it's initial post of October 1st 2012."

Answered by AI

To what capacity is the current trial recruiting participants?

"Affirmative. According to information available on clinicaltrials.gov, this medical trial is still recruiting participants; the listing was published on October 1st 2012 and most recently updated August 30th 2021. This research requires 20 patients from one site location."

Answered by AI

Does this research project admit individuals over the age of fifty?

"The lowest age of admission to this trial is 5 years old and the upper limit is 18."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Evaluation of PET/MRI in Children With Cancer
Michael Gee 2012. "Evaluation of PET/MRI in Children With Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01839747.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top